HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2016 | $42.8 M |
2017 | $55.8 M |
Total: | $98.6 M |
Period | Weight, tons. |
---|---|
2016 | 710 |
2017 | 2.22 K |
Total: | 2.93 K |
Group product | 2016 | 2017 | Ch. | ∑ (2016-2017) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | --- | --- | --- | --- | 0% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | $42.8 M | $55.7 M | 30% | $98.5 M | 99.9% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | $33.1 K | $24.4 K | 26% | $57.4 K | 0.1% |
Total: | $42.8 M | $55.8 M | $98.6 M |
№ | Country | ∑ (2016-2017) | Ratio |
---|---|---|---|
1 | Netherlands | $98.6 M | 77.6% |
2 | France | $17.2 M | 13.6% |
3 | Belarus | $5.5 M | 4.3% |
4 | Argentina | $1.5 M | 1.2% |
5 | Ukraine | $1.4 M | 1.1% |
6 | Bulgaria | $861 K | 0.7% |
7 | Germany | $672 K | 0.5% |
8 | Belgium | $613 K | 0.5% |
9 | United States | $498 K | 0.4% |
10 | India | $134 K | 0.1% |
11 | Uruguay | $106 K | 0.1% |
12 | Kazakhstan | $35.7 K | 0% |
13 | United Kingdom | $11.6 K | 0% |
14 | Israel | $10.8 K | 0% |
15 | Italy | $9.68 K | 0% |
The total for all countries: | $127 M | 100% |
№ | Region | ∑ (2016-2017) | Ratio |
---|---|---|---|
1 | Moskva | $501 M | 67.8% |
2 | Moskovskaya oblast | $139 M | 18.8% |
3 | Belgorodskaya oblast | $98.6 M | 13.3% |
4 | Chechenskaya respublika | $170 K | 0% |
5 | Sankt-Peterburg | $102 K | 0% |
6 | Chelyabinskaya oblast | $32.8 K | 0% |
7 | Nijegorodskaya oblast | $30.1 K | 0% |
8 | Krasnodarskiy kray | $3.57 K | 0% |
9 | Vladimirskaya oblast | $2.14 K | 0% |
10 | Smolenskaya oblast | $99 | 0% |
By all regions: | $739 M | 100% |